USDA Gives Conditional License for Bird Flu Vaccine Given to Chickens
The U.S. Department of Agriculture (USDA) has issued a conditional license approval for an inactivated avian flu (bird flu) vaccine to be administered to chickens eaten by Americans. The license is being granted due to H5N1 influenza virus infections spreading in U.S. poultry. The United States has avoided giving H5N1 vaccine to until now. The […]
Pfizer Agrees to Settle Zantac Cancer Lawsuits for $250 Million
Pfizer, Inc., the largest pharmaceutical corporation in the world marketing drugs and vaccines,1 has agreed to pay between $200 to $250 million to settle more than 10,000 lawsuits filed in the United States related to cancer risks associated with its over-the-counter heartburn drug Zantac (also known as ranitidine). The acid reflux drug was discontinued in […]
CDC Reports Errors in RSV Vaccines Given to Pregnant Woman, Monoclonal Antibody Shots to Children
A new problem involving the RSV (Respiratory Syncytial Virus) vaccines given to adults over age 60 and monoclonal antibody shots given to infants and children has been highlighted in a recent emergency newsletter called the U.S. Centers for Disease Control and Prevention (CDC) Clinician Outreach and Communication Activity, which is distributed to health care providers.1 […]
U.S. Vaccine Industry Harvesting Blood from Horseshoe Crabs
For many decades, the blue colored blood from horseshoe crabs has been harvested for purposes of medical research and for quality control and safety testing in vaccines, prosthetics and intravenous drugs. Their eggs are also a staple food for a shorebird bird known as the red knot, which is listed as threatened under the Endangered […]
Ozempic Weight Loss Drug Linked to Increased Risk of Thyroid Cancers
New weight loss drug Ozempic has taken the world’s obesity epidemic by storm, but like most weight loss drugs that precede it over the past century, shedding extra pounds may not be the only outcome for consumers: Last month, the European Medicines Agency (EMA), a European Union (E.U.) agency that oversees and evaluates pharmaceutical medications, […]
Twelve Infants Die During Clinical Trials for FDA-Endorsed RSV Drug
On June 8, 2023, the U.S. Food and Drug Administration’s (FDA) Antimicrobial Drugs Advisory Committee (AMDAC) voted unanimously (21-0) in favor of AstraZeneca and Sanofi’s new nirsevimab (Beyfortus) monoclonal antibody drug believed to provide protection for infants from respiratory syncytial virus (RSV) disease and other lower respiratory tract infections during their first year of life.1 […]